Methods and compositions for inhibition of angiogenesis
AssigneeEntreMed, Inc.
InventorsShawn J. Green, Glenn M. Swartz JR., Jamshed H. Shah, John Madsen, Robert J. D'Amato
Life of this patent
Estimating the term…
Abstract
The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, the invention comprises the compound EM-138 and its use in the inhibition of angiogenesis and treatment of angiogenesis associate diseases, including the inhibition of tumor growth and metastasis.
Claims87
A method of treating undesired angiogenesis comprising administering to a human or animal with undesired angiogenesis a composition comprising an effective amount of EM-138.
The method of claim I wherein the undesired angiogensis occurs in epidemic keratoconjunctivitis.
Dependencies are inferred from the claim text.